CUE1 - A device for Parkinson's
Medical device
The CUE1 was developed for people with Parkinson’s that utilises pulsed cueing and focussed vibrotactile stimulation to alleviate symptoms including freezing of gait, resulting in improved movement. The CUE1 offers a novel, non-invasive approach to improving quality of life for people with Parkinson’s, with the simple push of a button. The CUE1 device has been developed for and extensively tested with people with Parkinson’s, neurologists and clinical advisors. We hope that this will afford people with Parkinson’s increased independence, increased ability to remain active, and reduce the risk of falls due to mobility impairments.
Client / Manufacturer
Design
Charco Neurotech
Cambridge, GBCharco Neurotech
Cambridge, GBCharco NeurotechDate of Launch
2021
Development Time
Confidential
Target Regions
Europe
Target Groups
Consumers / Users